Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24081937 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer
Condition: Carcinoma, Hepatocellular
Interventions: Drug: sunitinib malate;   Drug: sorafenib

Indicates status has not been verified in more than two years